Related Experiment Videos
Laminin-binding integrin alpha 7 beta 1: functional characterization and expression in normal and malignant
R H Kramer1, M P Vu, Y F Cheng
1Department of Stomatology, University of California, San Francisco 94143.
Cell Regulation
|October 1, 1991
Summary
A novel alpha 7 beta 1 integrin binds laminin's E8 region on melanoma cells. This integrin is absent in normal melanocytes, suggesting a role in cancer development.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Integrins are crucial cell surface receptors mediating cell-matrix and cell-cell adhesion.
- Laminin is a key component of the extracellular matrix involved in cell differentiation, migration, and survival.
- Melanoma, a type of skin cancer, exhibits altered expression of adhesion molecules.
Purpose of the Study:
- To identify and characterize novel integrins involved in melanoma cell adhesion.
- To investigate the binding specificity of the identified integrin to laminin.
- To determine the potential role of this integrin in melanoma pathogenesis.
Main Methods:
- Laminin-affinity chromatography was used to purify the integrin complex from melanoma cells.
- Gel electrophoresis and N-terminal amino acid sequencing were employed to identify the integrin subunits.
- Binding assays using specific laminin fragments (E8 and P1) were performed to determine the binding site.
Main Results:
- A novel integrin, alpha 7 beta 1, was identified and purified from human and murine melanoma cells.
- N-terminal sequencing confirmed alpha 7 beta 1 as a distinct integrin, similar to alpha 6.
- The alpha 7 beta 1 integrin selectively binds to the E8 region of laminin, not the P1 fragment.
- Alpha 7 beta 1 was commonly expressed in melanoma cells but not detected in normal melanocytes.
Conclusions:
- The alpha 7 beta 1 integrin represents a novel receptor that binds to the E8 domain of laminin.
- This integrin mediates melanoma cell adhesion to laminin.
- Its selective expression in melanoma suggests a potential association with malignant transformation.